SANUWAVE, Inc. Issued U.S. Patent for the Application of Acoustic Shock Waves Utilizing its PACE Devices

Published: Jan 06, 2012

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled “Device for the Application of Acoustic Shock Waves.”

Back to news